Cargando…

Elevated plasma WIF‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension

AIMS: Heart failure (HF) is a progressive condition that is becoming more prevalent in the ageing population. Pulmonary hypertension is a common complicating factor in HF and negatively impacts survival. Plasma biomarkers are a potential method for determining the prognosis of patients with left hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kania, Kriss, Ahmed, Abdulla, Ahmed, Salaheldin, Rådegran, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773778/ https://www.ncbi.nlm.nih.gov/pubmed/36082780 http://dx.doi.org/10.1002/ehf2.14148

Ejemplares similares

Plasma tumour necrosis factor‐alpha‐related proteins in prognosis of heart failure with pulmonary hypertension
por: Engel Sällberg, Adam, et al.
Publicado: (2023)

Adrenomedullin peptides and precursor levels in relation to haemodynamics and prognosis after heart transplantation
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Data on plasma tumour and metabolism related proteins’ potential in differentiation of HFpEF-PH from PAH and in prognosis of left heart failure patients with pulmonary hypertension
por: Ahmed, Salaheldin, et al.
Publicado: (2021)

Plasma ADAMTS13 and von Willebrand factor in diagnosis and prediction of prognosis in pulmonary arterial hypertension
por: Ahmed, Abdulla, et al.
Publicado: (2021)

Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics
por: Ahmed, Salaheldin, et al.
Publicado: (2020)

Elevated plasma sRAGE and IGFBP7 in heart failure decrease after heart transplantation in association with haemodynamics
por: Ahmed, Abdulla, et al.
Publicado: (2020)

Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics
por: Ahmed, Salaheldin, et al.
Publicado: (2020)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Plasma Biomarkers for Clinical Assessment of Bone Mineral Density in Heart Transplanted Patients—A Single-Center Study at Skåne University Hospital in Lund
por: Löfdahl, Eveline, et al.
Publicado: (2022)

Prolargin and matrix metalloproteinase‐2 in heart failure after heart transplantation and their association with haemodynamics
por: Ahmed, Abdulla, et al.
Publicado: (2019)

Plasma receptor tyrosine kinase RET in pulmonary arterial hypertension diagnosis and differentiation
por: Säleby, Joanna, et al.
Publicado: (2019)

Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2021)

Plasma matrix metalloproteinase 2 is associated with severity and mortality in pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2022)

Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
por: Arvidsson, Mattias, et al.
Publicado: (2019)

Increased right atrial volume measured with cardiac magnetic resonance is associated with worse clinical outcome in patients with pre‐capillary pulmonary hypertension
por: Bredfelt, Anna, et al.
Publicado: (2018)

Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation
por: Lundgren, Jakob, et al.
Publicado: (2015)

Wearable defibrillator use in heart failure (WIF): results of a prospective registry
por: Kao, Andrew C, et al.
Publicado: (2012)

Low plasma stem cell factor combined with high transforming growth factor-α identifies high-risk patients in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2018)

WIF1 causes dysfunction of heart in transgenic mice
por: Lu, Dan, et al.
Publicado: (2013)

Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
por: Bouzina, Habib, et al.
Publicado: (2019)

Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Perceptions of Received Information, Social Support, and Coping in Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2014)

Coping, social support and information in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A 2-year retrospective cohort study
por: Ivarsson, Bodil, et al.
Publicado: (2018)

Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
por: Ivarsson, Bodil, et al.
Publicado: (2019)

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension
por: Wuttge, Dirk M, et al.
Publicado: (2021)

Epigenetic regulation of human WIF1 and DNA methylation situation of WIF1 and GSTM5 in urothelial carcinoma
por: Shen, Cheng-Huang, et al.
Publicado: (2023)

Deranged Lung Perfusion Pattern in Patients With Heart Failure Normalizes After Heart Transplantation
por: Al-Mashat, Mariam, et al.
Publicado: (2020)

Cognitive performance is associated with worse prognosis in patients with heart failure with reduced ejection fraction
por: Fino, Patrícia, et al.
Publicado: (2020)

Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
por: Sandqvist, Anna, et al.
Publicado: (2017)

An Eye on the Wnt Inhibitory Factor Wif1
por: Poggi, Lucia, et al.
Publicado: (2018)

Pulmonary Hypertension in Heart Failure
por: Jang, Albert Youngwoo, et al.
Publicado: (2021)

Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization
por: Jögi, Jonas, et al.
Publicado: (2018)

Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension
por: McCullagh, Brian N., et al.
Publicado: (2015)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension
por: Cai, Zongye, et al.
Publicado: (2020)

Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: A Swedish single‐center study
por: Kallonen, Janica, et al.
Publicado: (2023)

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma
por: Liu, Pei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mdfenlonrfgnbdibg3467ft8ii